Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANDREA M COSTANZA

Allopathic & Osteopathic Physicians Dermatology

NPI
1033243175
CMS profile
228661
Location
HILLIARD, OH

General Payments · PY2018–2024

$3,779.74

  • Reported across 231 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$243.09

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $243.09 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $42.90 2
Arcutis Biotherapeutics, Inc. $39.25 2
UCB, Inc. $28.35 1
MAYNE PHARMA COMMERCIAL LLC $25.87 4
Lilly USA, LLC $25.75 1
E.R. Squibb & Sons, L.L.C. $25.40 1
Janssen Biotech, Inc. $24.85 1
ABBVIE INC. $15.44 1
PFIZER INC. $15.28 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,421.49 102
PY2019 $1,035.19 69
PY2020 $206.18 8
PY2021 $114.21 4
PY2022 $405.07 14
PY2023 $354.51 20
PY2024 $243.09 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.44 04/25/2024 Food and Beverage Undisputed 01/23/2026 1103506020 CMS
Arcutis Biotherapeutics, Inc. $18.75 03/07/2024 Food and Beverage Undisputed 01/23/2026 1121034646 CMS
Arcutis Biotherapeutics, Inc. $20.50 08/29/2024 Food and Beverage Undisputed 01/23/2026 1121034648 CMS
E.R. Squibb & Sons, L.L.C. $25.40 09/26/2024 Food and Beverage Undisputed 01/23/2026 1101198330 CMS
Incyte Corporation $28.47 04/04/2024 Food and Beverage Undisputed 01/23/2026 1141182716 CMS
Incyte Corporation $14.43 08/21/2024 Food and Beverage Undisputed 01/23/2026 1141183630 CMS
Janssen Biotech, Inc. $24.85 05/09/2024 Food and Beverage Undisputed 01/23/2026 1078505216 CMS
Lilly USA, LLC $25.75 11/14/2024 Food and Beverage Undisputed 01/23/2026 1136039969 CMS
MAYNE PHARMA COMMERCIAL LLC $5.49 02/02/2024 Food and Beverage Undisputed 01/23/2026 1154680163 CMS
MAYNE PHARMA COMMERCIAL LLC $6.71 07/19/2024 Food and Beverage Undisputed 01/23/2026 1154680225 CMS
MAYNE PHARMA COMMERCIAL LLC $7.27 08/02/2024 Food and Beverage Undisputed 01/23/2026 1154680185 CMS
MAYNE PHARMA COMMERCIAL LLC $6.40 08/30/2024 Food and Beverage Undisputed 01/23/2026 1154680203 CMS
PFIZER INC. $15.28 10/31/2024 Food and Beverage Undisputed 01/23/2026 1131117347 CMS
UCB, Inc. $28.35 02/08/2024 Food and Beverage Undisputed 01/23/2026 1143130244 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.